venBio Partners LLC
venbio.com Direct investor
venBio is a life sciences investment firm founded in 2011, with venture funds comprising nearly $1.1 billion in committed capital. It focuses on novel therapeutics for unmet medical needs and partners with industry leaders to build medicines and technologies.
venBio Partners LLC is a venture capital firm headquartered in San Francisco, United States, founded in 2011. It invests directly in companies, from seed to Series C and later, in life sciences, novel therapeutics and biotech. $1.1 billion under management, as it reports.
“We are a life sciences investment firm partnering with industry leaders to build game-changing medicines and technologies with a focus on novel therapeutics for unmet medical needs.”
— venBio Partners LLC, own website
- Layer
- Direct investor
- Type
- Venture capital
- Headquarters
- San Francisco, United States
- Sectors
- life sciences, novel therapeutics, biotech
- Founded
- 2011
- Assets under management
- $1.1 billion
Team, as venBio Partners LLC publishes it
- Corey Goodman Co-founder and Managing Partner
- Aaron Royston Managing Partner
- Richard Gaster Managing Partner
- Yvonne Yamanaka Partner
- Parthiv Patel Analyst
- Robert Adelman Co-founder and Emeritus Managing Partner
- David Pezeshki Chief Financial Officer
- Daniel Teichmann Controller
Names and roles exactly as listed on venbio.com. Nothing else about these people is recorded.
Most shared portfolio companies with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 97 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.
- Frazier Life Sciences Management, LP 4 shared companies: veronapharma.com, parabilismed.com, akerotx.com, 35pharma.com
- Sofinnova Investments, INC. 4 shared companies: apellis.com, aeovian.com, mareatx.com, rayzebio.com
- Foresite Capital 4 shared companies: akerotx.com, alumis.com, alxoncology.com, candidrx.com
- Samsara BioCapital, LLC 4 shared companies: alumis.com, neurogastrx.com, acelyrin.com, rayzebio.com
- Aisling Capital Management LP 3 shared companies: veronapharma.com, jnj.com, harmonybiosciences.com
- Atlas Venture 3 shared companies: calderatx.com, jnj.com, akerotx.com
- OrbiMed 3 shared companies: alumis.com, candidrx.com, neurogastrx.com
- TCG Crossover Management, LLC 3 shared companies: candidrx.com, rayzebio.com, vicebio.com
- Civilization Ventures 2 shared companies: insamo.com, axonis.us
- Avoro Capital Advisors LLC 2 shared companies: apellis.com, vicebio.com
and 87 more — the graph.
Where this comes from
Every fact above was read from a page venBio Partners LLC publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.venbio.com/name, is_investor, layer, type, hq_country, hq_city, sectors, thesis_quote, thesis_quote_page, description, founded, aum, status
- https://www.venbio.com/portfolio/stage_min, stage_max
- https://www.venbio.com/team/people
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 3070 · added 2026-09-03 · link last verified 2026-10-21 · confidence high
Similar investors
- BridgeX VenturesVenture capital · Pre-seed – Growth · San Francisco, United States
- Mission Bay CapitalVenture capital · Seed – Series A · San Francisco, United States
- The Column GroupVenture capital · Seed – Growth · San Francisco, United States
- Versant VenturesVenture capital · Seed – Growth · San Francisco, United States
- 7G BioVenturesVenture capital · Burlingame, United States
- AbstractVenture capital · Seed – Series A · San Francisco, United States